CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation.

Saved in:
Bibliographic Details
Title: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation.
Authors: Malagola M; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. michele.malagola@unibs.it., Radici V; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Farina M; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Pellizzeri S; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Spoldi F; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Morello E; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Polverelli N; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Buttini EA; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Bernardi S; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; Centro di Ricerca Emato-oncologico AIL (CREA), 'ASST-Spedali Civili' Hospital, Brescia, Italy., Re F; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; Centro di Ricerca Emato-oncologico AIL (CREA), 'ASST-Spedali Civili' Hospital, Brescia, Italy., Leoni A; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; Centro di Ricerca Emato-oncologico AIL (CREA), 'ASST-Spedali Civili' Hospital, Brescia, Italy., Signorini L; Unit of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Caruso A; Institute of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy., Russo D; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, 'ASST-Spedali Civili' Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Source: Bone marrow transplantation [Bone Marrow Transplant] 2024 Jan; Vol. 59 (1), pp. 138-140. Date of Electronic Publication: 2023 Oct 19.
Publication Type: Letter
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5365
DOI:10.1038/s41409-023-02124-y